ABT
Abbott Laboratories price
-2.28% Past Week
Market Cap
174.02B
Day’s Range
52W Range
Volume (3M)
4.48M
Price-Earnings Ratio
34.18
Revenue
40.23B
Abbott Laboratories Latest News
Abbott Laboratories (NYSE:ABT) Position Increased by Twelve Points Wealth Management LLCEIN News Pharmaceuticalsabout 12 hours agoTwelve Points Wealth Management LLC Purchases 144 Shares of Abbott Laboratories (NYSE:ABT)The AM Reporterabout 15 hours agoCambridge Investment Research Advisors Inc. Increases Stock Position in Abbott Laboratories (NYSE:ABT)EIN News Pharmaceuticalsabout 17 hours agoAbout Abbott Laboratories
Abbott Laboratories offers pharmaceutical, diagnostic, and nutritional products, as well as medical devices to treat cardiovascular disease and diabetes care products. Operating internationally, the company was founded in 1888 and has its headquarters in Chicago, Illinois. Abbot Laboratories stock is listed on the NYSE under the ticker ABT. Obtain the most recent ABT stock news by adding this instrument to your eToro watchlist.
Show MoreRobert B. Ford, MBA
CEO
115K
Employees
1888
Founded
Abbott Park, Illinois, US
HQ
Upcoming Events
18
OCT
REPORTS
Abbott Laboratories Q3 2023 earnings report is expected to be released before market open
Consensus
Strong Buy
Price Target
125.67
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
59
High
Industry
Avg. 51
65
Environment
60
Social
54
Governance
People Also Bought
AMGN Amgen Inc 2.71% 
GILD Gilead Sciences Inc 0.07% 
TMO Thermo Fisher Scientific Inc -0.76% 
BMY Bristol-Myers Squibb Co 0.26% 
AZN AstraZeneca PLC ADR 1.93%